PT  - JOURNAL ARTICLE
AU  - Ernest Suresh
AU  - Bo Abrahamsen
TI  - Denosumab: A novel antiresorptive drug for osteoporosis
AID  - 10.3949/ccjm.82a.13173
DP  - 2015 Feb 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 105--114
VI  - 82
IP  - 2
4099  - http://www.ccjm.org/content/82/2/105.short
4100  - http://www.ccjm.org/content/82/2/105.full
SO  - Cleve Clin J Med2015 Feb 01; 82
AB  - Denosumab is a novel antiresorptive drug that has been approved for use as a first-line drug for primary and secondary prevention of osteoporotic fractures. The authors discuss the mechanism of action of denosumab, review the evidence for its efficacy and safety in patients with osteoporosis, and offer recommendations for its use in clinical practice.